Research ArticleCELLULAR AND MOLECULAR
Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells
Michele T. Yip-Schneider, Patrick J. Klein, Sabrina C. Wentz, Amer Zeni, Alex Menze and C. Max Schmidt
Journal of Pharmacology and Experimental Therapeutics June 2009, 329 (3) 1063-1070; DOI: https://doi.org/10.1124/jpet.108.147306
Michele T. Yip-Schneider
Patrick J. Klein
Sabrina C. Wentz
Amer Zeni
Alex Menze
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCELLULAR AND MOLECULAR
Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells
Michele T. Yip-Schneider, Patrick J. Klein, Sabrina C. Wentz, Amer Zeni, Alex Menze and C. Max Schmidt
Journal of Pharmacology and Experimental Therapeutics June 1, 2009, 329 (3) 1063-1070; DOI: https://doi.org/10.1124/jpet.108.147306
Research ArticleCELLULAR AND MOLECULAR
Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells
Michele T. Yip-Schneider, Patrick J. Klein, Sabrina C. Wentz, Amer Zeni, Alex Menze and C. Max Schmidt
Journal of Pharmacology and Experimental Therapeutics June 1, 2009, 329 (3) 1063-1070; DOI: https://doi.org/10.1124/jpet.108.147306
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement